Integrated Biobanking and Tumor Model Establishment of Human Colorectal Carcinoma Provides Excellent Tools for Preclinical Research

Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer

(2019) Luca Lazzari et al.   CLINICAL CANCER RESEARCH

Genomic heterogeneity in primary colorectal carcinomas and their metastases: born bad or brought up a villain?

(2018) Maja Hühns et al.   HUMAN PATHOLOGY

Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies

(2018) Mariangela Russo et al.   Nature Communications

Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line

(2018) Michael Gock et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines

(2018) Michael Gock et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts

(2018) Magdalena Cybulska et al.   Biomed Research International

Modeling of Patient-Derived Xenografts in Colorectal Cancer

(2017) Anastasia Katsiampoura et al.   MOLECULAR CANCER THERAPEUTICS

Frameshift mutational target gene analysis identifies similarities and differences in constitutional mismatch repair-deficiency and Lynch syndrome

(2017) Claudia Maletzki et al.   MOLECULAR CARCINOGENESIS

Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

(2017) Chantal Pauli et al.   Cancer Discovery

Colorectal carcinoma tumour budding and podia formation in the xenograft microenvironment

(2017) Friedrich Prall et al.   PLoS One

The ghosts of HeLa: How cell line misidentification contaminates the scientific literature

(2017) Serge P. J. M. Horbach et al.   PLoS One

Improved survival of colorectal cancer in Denmark during 2001–2012 – The efforts of several national initiatives

(2016) Lene H. Iversen et al.   ACTA ONCOLOGICA

Establishment and characterization of HROC69 – a Crohn´s related colonic carcinoma cell line and its matched patient-derived xenograft

(2016) Florian Kuehn et al.   Scientific Reports

Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients

(2015) Marc van de Wetering et al.   CELL

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

(2015) Hui Gao et al.   NATURE MEDICINE

Correlation between tumor engraftment in patient-derived xenograft models and clinical outcomes in colorectal cancer patients

(2015) Bo Young Oh et al.   Oncotarget

Development and characterization of a colon PDX model that reproduces drug responsiveness and the mutation profiles of its original tumor

(2013) Hyang Sook Seol et al.   CANCER LETTERS

A Personalized Preclinical Model to Evaluate the Metastatic Potential of Patient-Derived Colon Cancer Initiating Cells

(2013) I. Puig et al.   CLINICAL CANCER RESEARCH

The “North German Tumor Bank of Colorectal Cancer”: status report after the first 2 years of support by the German Cancer Aid Foundation

(2013) Martina Oberländer et al.   LANGENBECKS ARCHIVES OF SURGERY

Establishment, Characterization and Chemosensitivity of Three Mismatch Repair Deficient Cell Lines from Sporadic and Inherited Colorectal Carcinomas

(2013) Claudia Maletzki et al.   PLoS One

Establishment and Characterization of Primary Glioblastoma Cell Lines from Fresh and Frozen Material: A Detailed Comparison

(2013) Christina Susanne Mullins et al.   PLoS One

Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer

(2012) S. Julien et al.   CLINICAL CANCER RESEARCH

Comprehensive molecular characterization of human colon and rectal cancer

(2012)   NATURE

ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells

(2011) Xuefeng Liu et al.   AMERICAN JOURNAL OF PATHOLOGY

A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

(2011) A. Bertotti et al.   Cancer Discovery

Biomarker-Driven Early Clinical Trials in Oncology

(2010) Daniel S. W. Tan et al.   CANCER JOURNAL

Colorectal Cancer Incidence Trends in the United States and United Kingdom: Evidence of Right- to Left-Sided Biological Gradients with Implications for Screening

(2010) R. Meza et al.   CANCER RESEARCH